Delhi
Homoeopathic Doctors Rally In Support Of National Medical Commission Bill
Support for National Medical Commission Bill
Support for National Medical Commission Bill
New Delhi: Homoeopathic doctors bodies today came together at the Ramlila Maidan here in support of a Bill that might allow doctors pursuing Indian systems of medicine to practice allopathy after clearing a bridge course.
The National Medical Commission Bill, 2017, which seeks to replace the existing apex medical education regulator Medical Council of India (MCI) with a new body, was moved by the government recently.
One of its recommendations includes that specific educational modules or programmes be introduced to bridge various systems of medicine and promote medical pluralism, with the approval of bodies concerned.
Dr Sunil Takalkar, core committee member of the All India Homoeopathic Doctors Association, said that they were holding a two-day rally to support the Bill as it will enhance the quality of services being rendered to patients.
This Bill would also provide special facilities to the people living in rural and remote areas, where allopathic medicines are not available.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!